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Background: Infections classified as group 1 biological carcinogens include the helminthiases caused by
Schistosoma haematobium and Opisthorchis viverrini. The molecular mediators underlying the infection with these
parasites and cancer remain unclear. Although carcinogenesis is a multistep process, we have postulated that these
parasites release metabolites including oxysterols and estrogen-like metabolites that interact with host cell DNA.
How and why the parasite produce/excrete these metabolites remain unclear. A gene encoding a CYP enzyme was
identified in schistosomes and opisthorchiids. Therefore, it is reasonable hypothesized that CYP 450 might play a
role in generation of pro-inflammatory and potentially carcinogenic compounds produced by helminth parasites
such as oxysterols and catechol estrogens. Here, we performed enzymatic assays using several isoforms of CYP 450
as CYP1A1, 2E1 and 3A4 which are involved in the metabolism of chemical carcinogens that have been associated
with several cancer. The main aim was the analysis of the role of these enzymes in production of helminth-
associated metabolites and DNA-adducts.
Method: The effect of cytochrome P450 enzymes CYP 1A1, 2E1 and 3A4 during the interaction between DNA,
glycocholic acid and taurochenodeoxycholate sodium on the formation of DNA-adducts and metabolites
associated with urogenital schistosomiasis (UGS) and opisthorchiasis was investigated in vitro. Liquid
chromatography/mass spectrometry was used to detect and identify metabolites.
Main findings: Through the enzymatic assays we provide a deeper understanding of how metabolites derived
from helminths are formed and the influence of CYP 450. The assays using compounds similar to those previously
observed in helminths as glycocholic acid and taurochenodeoxycholate sodium, allowed the detection of
metabolites in their oxidized form and their with DNA. Remarkably, these metabolites were previously associated
with schistosomiaisis and opisthorchiasis. Thus, in the future, it may be possible to synthesize this type of
metabolites through this methodology and use them in cell lines to clarify the carcinogenesis process associated
with these diseases.
Principal conclusions: Metabolites similar to those detected in helminths are able to interact with DNA in vitro
leading to the formation of DNA adducts. These evidences supported the previous postulate that imply helminth-
like metabolites as initiators of helminthiases-associated carcinogenesis. Nonetheless, studies including these kinds
of metabolites and cell lines in order to evaluate its potential carcinogenic are required.
Keywords: (max. 10): Helminth infection, Malignancy, Schistosomiasis, Opisthorchiasis, Cytochrome P450, Oxysterol© The Author(s). 2019 Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/ze
* Correspondence: nuno.vale@ff.up.pt
2Department of Molecular Pathology and Immunology, Institute of
Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Rua de Jorge
Viterbo Ferreira 228, 4050-313 Porto, Portugal
3i3S, Instituto de Investigação e Inovação em Saúde, University of Porto, Rua
Alfredo Allen, 208, 4200-135 Porto, Portugal
Full list of author information is available at the end of the articlele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Gouveia et al. Infectious Agents and Cancer           (2019) 14:41 Page 2 of 9Background
More than 20% of cancers in the developing world are
caused by infections, including helminthiases [1]. In
addition to the direct impact on the development, health,
and prosperity of populations in endemic regions, chronic
infection with the liver fluke Opisthorchis viverrini and the
blood fluke Schistosoma haematobium leads to cholangio-
carcinoma (CCA), bile duct cancer, and squamous cell
carcinoma (SCC) of the urinary bladder, respectively. The
chronic infection with these helminths is recognized by
International Agency for Research on Cancer (IARC) as a
definitive cause of cancer [2].
These helminths produce and excrete metabolites, in-
cluding estrogens and oxysterols, that appear capable of
oxidation of host DNA, in turn leading to the formation
of depurinating DNA adducts and mutations in the gen-
ome of adjacent tissues acting as initiators of carcinogen-
esis [3–7]. The high-performance liquid chromatography
coupled with mass spectrometry (LC-MS/MS) analysis of
urine from individuals with urogenital schistosomiasis
(UGS) and bladder cancer revealed the presence of spe-
cific metabolites which may represent biomarkers for
diagnosis and prognosis of SCC [6]. These metabolites
were also identified in developmental stages of S. haema-
tobium and Opisthorchis viverrini [5–8]. Chronic infection
with the liver fluke, Opisthorchis felineus may mimic the
malignant transformation induced by O. viverrini infection
producing metabolites that interact with host DNA. In
addition, several DNA adducts were detected in biofluids
from hamsters experimentally-infected with O. felineus.
These findings may support the inclusion of the infection
with the liver fluke O. felineus as group 1 carcinogens by
the IARC [5].
The CYP450 enzymes are involved in several biological
processes such as biosynthesis of estrogen, conversion of
cholesterol into bile acids and its biotransformation [9, 10].
These enzymes include the CYP450 family members CYP
1A1, 2E1 and 3A4, involved in the metabolism of chemical
carcinogens, associated with breast and endometrium can-
cer in humans [11]. A gene encoding a CYP enzyme was
identified in schistosomes and opisthorchiids [12–14]. Ac-
cordingly, this family of enzymes might play a role in gen-
eration of pro-inflammatory and potentially carcinogenic
compounds produced by helminth parasites such as oxy-
sterols and catechol estrogens. The role of CYP 450 en-
zymes in the physiology and biochemistry of these flukes is
less well understood. However, it might contribute to cell
survival, drug resistance, maintenance and evolution of the
host-parasite relationships [13]. In case of O. felineus the
function of CYP450 has been linked to the excretory sys-
tem of the parasite and possibly to metabolism and detoxi-
fication as biotransformation of endogenous substrates
[13]. Nevertheless, it remains unclear whether trematode
CYP enzymes catalyze the synthesis of proinflammatoryand potentially carcinogenic compounds, e.g. oxysterols-
like and catechol-like estrogen quinone-like metabolites
known to be released by these flukes [6–8].
Previously, we have hypothesized that helminth-
derived metabolites may be able to interact with host
DNA [3, 4]. Here we conducted in vitro assays in order
to evaluate the role of CYP450 in the formation of car-
cinogenic metabolites [5–8]. Due to difficulties in isolat-
ing the metabolites detected on developmental stages of
the parasites or biofluids of infected individuals, we de-
cided to use commercially-available compounds, i.e. gly-
cocholic acid and taurochenodeoxycholate sodium.
Thus, we exposed exogenous DNA to glycocholic acid
and taurochenodeoxycholate sodium in the presence or
absence of CYP 450. Subsequently, we identified the re-
action products by liquid chromatography-mass spec-
trometry (LC-MS/MS).Materials and methods
Chemicals
Acetonitrile (ACN) and formic acid (HF), HPLC grade, were
obtained from Merck (Darmstadt, Germany). Glycocholic
acid hydrated (G2878-100MG), calf thymus DNA (D1501-
100MG), nicotinamide adenine dinucleotide phosphate
(NADPH, N7506-25MG), dimethyl sulfoxide (DMSO, D-
5879) and CYPExpress™ 1A1 (MTOXCE1A1-250MG), 2E1
(MTOXCE2E1-250MG) and 3A4 (MTOXCE3A4-250MG)
were purchased from Sigma/Merck (Sintra, Portugal). Taur-
ochenodeoxycholate sodium (20275) was purchased from
Cayman Chemical (Ann Arbor, Michigan, USA).CYP450 activity, interaction of precursor metabolites with
DNA and formation of DNA adducts
The structures of compounds glycocholic acid (1) and
taurochenodeoxycholate sodium (2) are shown in Fig. 1.
Stock solutions of both compounds were prepared in
DMSO. The compounds at final concentration of
100 μM were incubated with CYP1A1, CYP2E1 and
CYP3A4 (0.2 μM) in the presence of 1.4 μM of NADPH
and calf thymus DNA (3mM) in 67mM Na-K phos-
phate buffer (pH 7.2), in a total volume of 200 μL at
37 °C for 72 h [15, 16]. A control reaction was prepared
as described above but without CYP450 enzymes. In
addition, a well containing the matrix of reactions was
also prepared with NADPH, calf thymus and Na-K
buffer. Aliquots of the reaction mixture were collected at
24 and 72 h after the start of the reaction. The reaction
was stopped by addition of two volumes of ethanol
(EtOH) to precipitate DNA, which was recovered by
centrifugation. Thereafter, the supernatant was subjected
to analysis by LC-MS/MS. It should be noted that data
originated from matrix sample were subtracted (in LC/
MS) to eliminate its influence.
Fig. 1 DNA adducts that we have implicated previously in schistosomiasis and opisthorchiasis [5–8]. Molecules (1) and (2) are presented as
precursors. The ability of these compounds in interact with DNA in vitro leading to the formation of DNA adducts was investigated, along with a
role for cytochrome P450 enzymes in formation of the adducts
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chromatography mass spectrometry (LC-MS/MS) analysis
Detection and identification of metabolites and related
DNA-adducts by LC-MS/MS was undertaken using an
LTQ Orbitrap XL mass spectrometer (Thermo Fischer
Scientific, Bremen, Germany), fitted with an ultraviolet
(UV) photo diode assay (PDA) detector. Analysis of ali-
quots involved a single injection of 20 μL with an ACE
Equivalence 5 C18 (75 mm Х 3 mm i.d.) column. The
mobile phase consisted of 1% HF in water (A)/ACN (B)
mixtures. Elution proceeded at a flow rate of 0.5 ml/min.Eluates were monitored for 10 min, run with a mobile
phase gradient started with 80% A and 20% B. At that
point, B was increased linearly to 55% over 5min. The
gradient was returned to the starting proportion at 9
min and equilibrated for one minute. Data were col-
lected in positive electrospray ionization (ESI). The ca-
pillary voltage of the ESI was 28 kV, and its temperature
was 310 °C, flow rates of the sheath gas and auxiliary gas
(N2) were set to 40 and 10 (arbitrary units as provided
by software settings), respectively, and gas temperature
was 275 °C.
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Formation of glycocholic acid and
taurochenodeoxycholate sodium metabolites and DNA
adducts is independent of CYP 450
The chromatograms and ratio mass/charge (m/z) obtained
by LC-MS/MS analysis are shown in Additional files 1
and 2. With regard to the starting compounds, the pre-
cursor glycocholic acid (1) with molecular mass [M +
H] 466.32 was identified in all aliquots analyzed
(Additional file 3). Additionally, product spectra as ra-
tio mass/charge (m/z) 338 [M-3H20-C2H4NO2 +H]
+ and
412 [M-3H20 +H]
+ were identified as its metabolites, as pre-
viously described [17]. In contrast, taurochenodeoxycholate
sodium (2) (m/z 522.28) was not detected.
Through the analysis of the data obtained for aliquots
(Additional file 1), it was possible to observe that sample
(+CYP) at 24 h and control (−CYP) at 72 h included
more metabolites than (+CYP) at 72 h and (−CYP) at 24
h. Apparently, the number of metabolites on samples
decreased through the course of reaction. The opposite
effect was observed in the controls, i.e. at 24 h there
were fewer compounds than at 72 h; 43 vs 77. For the
samples (+CYP) during the course of the reaction, the
number of compounds decreased, suggesting that the re-
action in the presence of CYP450 was faster but might
lead to some transformation and, in turn, result in fewer
products. By contrast, in controls (−CYP) the number of
compounds slightly increased during the reaction which
suggested that reaction in the absence of CYP450 might
be slower, and lead to the formation of an elevated num-
ber of compounds. In turn, this might indicate that the
chemical transformation was less evident in controls
(−CYP) (Additional file 1).
Nevertheless, some of the metabolites detected were
common to 1) all aliquots; 2) samples (+CYP) (e.g. samples
at 24 and 72 h); 3) control (−CYP) (e.g. control at 24 and
72 h); 4) samples or control at same time of reaction (e.g.
sample and control at 24 h); 5) samples (+CYP) or control
(−CYP) on different time of reaction (e.g. sample at 24 and
control at 72 h); 6) to three different aliquots (e.g. sample
at 24, controls at 24 and 72 h) (Additional file 2). Generally,
the generated compounds were mostly metabolites of pre-
cursors in oxidized or catechol form and DNA-adducts
(Additional files 2 and 3). Indeed, samples and controls
at 24 h included several common metabolites that cor-
respond not only to oxidized metabolites (e.g. m/z
628.30, Additional file 3) but also DNA-adducts (e.g.
718.41, Additional file 3). The highest number of DNA ad-
ducts was observed in the sample (+CYP) at 24 h; how-
ever, some of these DNA-adducts were also detected on
control (−CYP) at 24 h. Similarly, some compounds either
in oxidized form or as DNA-adducts detected in samples
(+CYP) at 24 h were also present in controls (−CYP) at 72
h (e.g., m/z 734.40 and 801.43 Additional file 3). Sincemetabolites and related DNA-adducts were detected ei-
ther in samples (+CYP) or controls (−CYP) at the same or
at a different time of reaction, we hypothesize that their
formation was independent of the presence of CYP450.
Notably, the compounds that were common to three sam-
ples, (+CYP) at 24 and (−CYP) at 24 and 72 h were also
DNA adducts (e.g., m/z 566.34). Curiously, in comparison
(+CYP) at 24 and 72 h and (−CYP) at 72 h and (+CYP) 24
h and 72 h, most of the common compounds were frag-
ments of precursors (e.g., m/z 403.27, Additional file 3).
Comparing all exclusive metabolites obtained for all
aliquots, we observed that controls (−CYP) 72 h had the
most elevated number (56) but also the lowest at 24 h
(10) (Fig. 2). It was expected that the number of com-
pounds would be higher in samples (+CYP) than in the
controls (−CYP). However, as noted above, this could
suggest that the formation of metabolites and DNA
adducts was independent of CYP450, and that most of
the metabolites form through a chemical metabolization
that occurs in the reaction mixture, and not by enzym-
atic catalysis (Fig. 2).
Generally, the exclusive compounds were mainly me-
tabolites of precursors of glycocholic acid and tauroche-
nodeoxycholate sodium, and most of them were in
oxidized or catechol form [(e.g. m/z 541.21 at S24 h
(+CYP); m/z 509.24 at C72 h (−CYP)]. Interestingly, at
C24 h (−CYP) we did not observe exclusive metabolites
in oxidized or catechol forms (Additional file 4). All ali-
quots except C72 h (−CYP) presented DNA adducts
[e.g. m/z 616.34 at S24 h (+CYP); m/z 899.43 at C24h
(−CYP); m/z 598.75 at S72 h (−CYP)]. Regarding the
common metabolites, aliquots S24 h (+CYP) and C24 h
(−CYP) shared not only metabolites in oxidized form as
well as DNA-adducts (e.g. m/z 628). Similarly, this was
observed on S24 h (+CYP) and C72h (−CYP) (e.g. m/z
743.40), and S72 h (+CYP) and C72 h (−CYP) (e.g. m/z
612.44) (Fig. 2; Additional file 4). Additional files 3 and 4
present the common and exclusive postulated structures
of the metabolites and cognate DNA-adducts.
The metabolites and DNA-adducts are similar to those
identified during schistosomiasis and opisthorchiasis
In order to test if the in vitro assay leads to the synthesis of
metabolites related to schistosomiasis [6] and opisthorchia-
sis [5, 7], we compared the current data with published
findings [5–8]. The identities of common compounds were
confirmed by comparison of their mass spectra and
molecular mass (Fig. 2). Indeed, some metabolites and
DNA-adducts synthesized during the present assays
(e.g. m/z 600, 718, 804, Figs. 2 and 3) had been previ-
ously associated with these helminth infections [5, 7].
In addition, some metabolites detected here were iden-
tified as oxidized forms [M + 16] of those previously
described for helminthic infection [5, 6, 7] (Figs. 2 and 3).
Fig. 2 Exclusive m/z detected in control (−CYP) and samples (+CYP) during the course of the reaction. Several compounds that had been
detected previously within developmental stages of parasites and biofluids from mammalian hosts were synthesized in vitro in this study
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DNA-adducts, but were precursor metabolites.
Additionally, most of these compounds were detected on
control (−CYP) or were common to control (−CYP) and
samples (+CYP) suggesting that CYP450 was not critical to
produce electrophilic metabolites observed on flukes and
infected individuals (Figs. 2, 3). Based on these findings, we
could hypothesize that infection with the liver fluke might
have a potential role in the formation of DNA-adducts.
In addition, during this in vitro study, it was possible
to synthesize a new family of metabolites of glycocholic
acid (1) and taurochenodeoxycholate sodium (2), as well
as to demonstrate that these metabolites are able to
interact with DNA forming DNA-adducts. It should be
noted that some the metabolites and DNA adducts syn-
thesized here correspond to those previously related to
schistosomiasis and opisthorchiasis. Thus, we considerthat data presented here reinforce the notion that this
kind of compounds and the helminth-derived metabo-
lites, are capable to interact with host DNA and lead to
the formation of DNA-adduct. Therefore, these evi-
dences support, at least in part our postulated [3, 4].
Discussion
In this study, we performed an in vitro assay to investi-
gate the generation of some of the metabolites and re-
lated DNA-adducts previously identified in the context
of opisthorchiasis, schistosomiasis and their infection-
associated cancers [5, 6, 8]. The precursors, glycocholic
acid (1) and taurochenodeoxycholate sodium (2), were
chosen based on previous data that demonstrated cog-
nate DNA-adducts in developmental stages of parasites
and in biofluids of human cases and/or rodent models
of these helminth infections [5–8]. Using in vitro
Fig. 3 Mass/ratio (m/z) of metabolites and DNA adducts synthesized in vitro, and previously related to opisthorchiasis and schistosomiasis which
undergo hydroxylation (± 16 Da)
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interact with DNA leading to the formation of DNA
adducts.
Bile acids exhibit a diverse spectrum of biological ac-
tivity, being able to stimulate proliferation and tumor in-
vasiveness, inhibit apoptosis and modify the promoter
functions of genes involved in DNA synthesis, repair,
and oxidative stress [18, 19]. Bile acids are associated to
several carcinogen models, e.g. glycocholic acid was high
in urine of people with hepatocellular carcinoma [20].
Additionally, in human esophageal cell lines, acid and
bile salts, including glycocholic acid (1), caused elevated
DNA damage [20]. CYP450 enzymes are involved in the
generation of most chemical carcinogens that induce
genotoxicity and DNA damage [10, 21, 22]. CYP450 play
a critical role both in estrogen formation and itssubsequent metabolism, namely, CYP1A1 and CYP3A
which catalyze the hydroxylation preferentially at the 2-
position, whereas CYP1B1 catalyzes the hydroxylation
almost exclusive at the 4-position [23], leading formation
of catechol estrogen quinone form that can react with
DNA to form predominantly depurinating adducts.
We have previously hypothesized a similar pathway for
the genesis of parasite-derived metabolites [4]. Here, we
investigated the role of these enzymes in activation and/
or oxidation of parent compounds. Although CYP450
enzymes might be involved in formation of some metab-
olites detected in samples (+CYP), apparently, they were
not crucial during the metabolization of these com-
pounds to form DNA-adducts, since they were detected
in control aliquots (−CYP). The metabolites and oxi-
dized forms detected here were probably generated by
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some of oxidized metabolite were observed in samples
(+CYP). Therefore, we cannot rule out that these enzymes
play a role in the formation of oxidized metabolites since
involvement of CYP450 in the oxidation of several com-
pounds have been reported in previous study [26]. Appar-
ently, previous activation is not necessary for interaction
with DNA. Notably, the metabolites and DNA adducts
that were previously described [5–8], and synthesized here
for use in our in vitro assay, were generated in absence
of P450. This suggests that the formation of these me-
tabolites also might be independent of the parasite
CYP450.
Carcinogenesis is a complex process in which normal
cell growth is modified due interaction of multiple fac-
tors [27]. Malignant transformation follows a sequence
of steps that include a pathogenic stimulus (biological
and/or chemical) followed by a chronic inflammation, in
turn provoking fibrosis and changes in the cellular
microenvironment arising in a pre-cancerous niche [28].
In the cases of schistosomiasis and opisthorchiasis, we
have postulated that these pathogens provide biological
and chemical stimuli through parasite-derived metabo-
lites, e.g. oxysterols and catechol estrogens, that can
interact with host DNA to trigger a cascade of events ul-
timately leading to cancer [3–8]. Cholesterol, oxysterols
and estrogens are closely related steroids [29]. These
trematode parasites likely produce these steroid-like
compounds for endogenous physiological and repro-
ductive processes, but they| may also have evolved in
concert with the host-parasite relationship. Oxysterols
and/or catechol estrogens of trematode origin and/or
precursors modified as the consequence of opisthorchiasis
or UGS [2–8, 30] appear capable of modulating host
metabolic pathways of steroid hormones and bile acids
[31], and are potential initiators of carcinogenesis given
that these metabolites are genotoxic in other systems [32].
Since these infection-related initiators of cancer and/or
promoters might need to be metabolized for activation,
their carcinogenicity may be specific for organ systems,
tissues, and/or epithelia [1, 31].
Currently, little evidence supports the formation of
DNA damage directly by bile acids. The information is
controversial. Some authors state the impossibility of
formation bile acid-related DNA adduct in vitro [33, 34]
whereas, by contrast, others report that bile acids or
conjugates of glycocholic acid (1) and taurochenodeoxy-
cholate sodium (2) are responsible for the elevation of
DNA damage on esophageal cell lines [20, 35]. More-
over, bile acids and the oxidized forms, oxysterols, are
linked to development and progression of cancers of the
pancreas, colon, lung and breast [3, 36, 37]. With respect
to helminthic infections, opisthorchiasis is associated with
an elevation of bile acids, including deoxycholic acid,which is a potent promoter in cholangiocarcinogenesis
[7]. Indeed, several metabolites and DNA adducts detected
in this study have been implicated during schistosomiasis
and opisthorchiasis [5–8].
Helminth infections caused by Opisthorchis species
and S. haematobium are directly linked to malignancy
[2]. We have shown that metabolites excreted by para-
sites might act as chemical carcinogens and act as initia-
tors of carcinogenesis, through interaction with host
DNA [3, 4, 38]. Here, we demonstrated the in vitro gen-
eration of several metabolites of glycocholic acid (1) and
taurochenodeoxycholate sodium (2), precursors of
DNA-adducts related to opisthorchiasis and urogenital
schistosomiasis [5, 6, 8]. Also, we confirmed the ability
of these metabolites to interact with DNA leading to the
formation of DNA-adducts. The activation and subse-
quent formation of DNA-adducts seem to be performed
through a CYP450-independent pathway, at least
CYP1A1, CYP1B1, and CYP3A4. Some of the metabo-
lites previously detected in the helminths themselves
and infected people, and in a rodent model of infection,
were synthesized in this study (Figs. 2, 3). Future studies
using informative cell lines can be expected to define the
carcinogenic roles of these metabolites.
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